AXSM
Axsome Therapeutics Inc
168.40$
-1.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -1,883.3% | – | – | – | |
| – | -0.2% | +5.2% | +8.8% | +3.4% | +0.6% | -17.0% | -0.7% | +41.1% | -5.7% | +4.1% | -55.5% | – | |
| – | +27.5% | +6.7% | +5.9% | +1.3% | +1.5% | +6.0% | +5.6% | -6.1% | -1.6% | +3.1% | +15.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -298.7% | – | -170.3% | – | -179.3% | – | – | -177.7% | – | -165.7% | – | |
| – | -98.1% | +1,300.0% | -46.9% | +188.5% | -80.0% | +1,026.7% | -96.2% | +346.2% | +22.4% | +70.4% | +0.0% | – | |
| – | -98.1% | +1,300.0% | -46.9% | +73.1% | -66.7% | +1,026.7% | -96.2% | +346.2% | +22.4% | +70.4% | +271.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -21.1% | +477.9% | -17.9% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +6.1% | +21.5% | +524.9% | -73.5% | -18.5% | +24.2% | +80.1% | – | |
| – | -100.0% | +59,250.0% | – | +111.5% | -53.2% | +105.5% | +18.0% | -38.4% | -23.0% | -81.7% | +1,508.1% | – | |
| – | – | – | – | – | -202.6% | – | – | +956.8% | -110.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | -1,995.1% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.